We are monitoring the impact of COVID-19 on North America TAVR Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 316
Share on
Share on

North America Transcatheter Aortic Valve Replacement Market Research Report – Segmented By Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users & Country (the United States, Canada and Rest of North America) – Analysis on Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 316
Pages: 145

North America TAVR Market Size (2021 to 2026)

The size of the North American Transcatheter Aortic Valve Replacement Market is forecasted to grow USD 1.57 billion by 2021 from USD 0.72 billion in 2021, growing at a CAGR of 16.80% between 2021 to 2026.

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high-risk patients. Transcatheter heart valve replacement systems are referred to as cardiovascular devices that replace the old and damaged valves. TAVR is used to treat aortic valve disorders such as severe aortic stenosis, degeneration, & regurgitation. Transcatheter aortic valve replacement devices are integrated with valve frame (made of nitinol or stainless steel), valve leaflets material (made of bovine or cow heart tissue). These aortic valves are available with varied sizes (such as 14mm, 16mm, 18mm, 20mm, 22mm, & 29mm). TAVR is performed during different surgery methods such as transfemoral implantation (through the femoral artery), transapical implantation (through the apex of the heart), transaortic implantation (through the top of the right chest), and transcranial implantation (through the femoral vein).

The increasing number patient population adopting transcatheter heart valve therapy in the U.S., availability of reimbursement systems for TAVR procedures, a growing number of clinical trials for new products by manufacturers, and rising demand for transcatheter heart valve surgery in Canada are driving the growth of transcatheter aortic valve replacement (TAVR) market in North America.

However, the high cost of the transcatheter aortic valves and certain risks associated with TAVR therapy are expected to restrain the transcatheter aortic valve replacement (TAVR) market in North America.

This research report on the North American TAVR Market has been segmented and sub-segmented into the following categories:

By Surgery Method:

  • Transfemoral Implantation
  • Transapical Implantation
  • Transaortic Implantation
  • Transvaal Implantation                  

By Valve Material:

  • Nitinol
  • Stainless Steel
  • Cobalt-Chromium              

By Valve Size:

  • 14mm to 18 mm
  • 18mm to 22 mm
  • 22mm to 29mm                    

By Valve Leaflets Material:

  • Bovine Heart Tissue
  • Cow Heart Tissue
  • Other Valve Leaflets Material                       

By End Users:

  • Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Catheterization Laboratories     

By Country:

  • The United States
  • Canada
  • Rest of North America

Regionally, the U.S. accounted for a larger share of the North America Transcatheter Aortic Valve Replacement (TAVR) market in 2019. In contrast, Canada is estimated to grow at a higher CAGR during the forecast period.

Companies playing a dominant role in the North America Transcatheter Aortic Valve Replacement Market profiled in this report are Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India) and Braile Biomedica (Brazil).

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Introduction                                               

                5.2 Surgery Method                                       

                                5.2.1 Introduction                           

                                5.2.2 Transfemoral Implantation                              

                                5.2.3 Transapical Implantation                   

                                5.2.4 Transaortic Implantation                   

                                5.2.5 Transcaval Implantation                    

                5.3 Valve Material                                           

                                5.3.1 Introduction                           

                                5.3.2 Nitinol                       

                                5.3.3 Stainless Steel                       

                                5.3.4 Cobalt-Chromium                

                5.4 Valve Size                                    

                                5.4.1 Introduction                           

                                5.4.2 14mm to 18 mm                    

                                5.4.3 18mm to 22 mm                    

                                5.4.4 22mm to 29mm                     

                5.5 Valve Leaflets Material                                          

                                5.5.1 Introduction                           

                                5.5.2 Bovine Heart Tissue                            

                                5.5.3 Cow Heart Tissue                 

                                5.5.4 Other Valve Leaflets Material                         

                5.6 End Users                                    

                                5.6.1 Introduction                           

                                5.6.2 Hospitals                  

                                5.6.3 Ambulatory Surgical Centres                           

                                5.6.4 Cardiac Catheterization Laboratories                           

6. Geographical Analysis                                                              

                                6.1 Introduction                               

                                6.2 United States                            

                                6.3 Canada                         

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Edwards Lifesciences Corporation (U.S.)                                       

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Medtronic, Inc. (Ireland)                                      

                8.3 Boston Scientific Corporation (U.S.)                                 

                8.4 Abbott Laboratories (U.S.)                                   

                8.5 St. Jude Medical Inc. (U.S.)                                  

                8.6 JenaValve Technology, Inc. (Germany)                                          

                8.7 Symetis SA (Switzerland)                                      

                8.8 Direct Flow Medical, Inc. (U.S.)                                          

                8.9 Sorin Group (Italy)                                   

                8.10 Meril Life Sciences India Pvt Ltd (India)                                        

                8.11 Braile Biomedica (Brazil)                                     

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Transcatheter Aortic Valve Replacement Market, By Region, From 2021 to 2026 (USD Billion)
  2. North America Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2021 to 2026 (USD Billion)
  3. North America Transfemoral Implantation Transcatheter Aortic Valve Replacement Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Transapical Implantation Transcatheter Aortic Valve Replacement Market, By Region, From 2021 to 2026 (USD Billion)
  5. North America Transaortic Implantation Market, By Region, From 2021 to 2026 (USD Billion)
  6. North America Transcaval Implantation Market, By Region, From 2021 to 2026 (USD Billion)
  7. North America Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2021 to 2026 (USD Billion)
  8. North America Nitinol Transcatheter Aortic Valve Frame Material Market, By Region, From 2021 to 2026 (USD Billion)
  9. North America Stainless Steel Transcatheter Aortic Valve Frame Material Market, By Region, From 2021 to 2026 (USD Billion)
  10. North America Cobalt-Chromium Transcatheter Aortic Valve Frame Material Market, By Region, From 2021 to 2026 (USD Billion)
  11. North America Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2021 to 2026 (USD Billion)
  12. North America 14mm to 18mm Transcatheter Aortic Valve Size Market, By Region, From 2021 to 2026 (USD Billion)
  13. North America 18mm to 22mm Transcatheter Aortic Valve Size Market, By Region, From 2021 to 2026 (USD Billion)
  14. North America 22mm to 29mm Transcatheter Aortic Valve Size Market, By Region, From 2021 to 2026 (USD Billion)
  15. North America Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2021 to 2026 (USD Billion)
  16. North America Bovine Heart Tissue Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2021 to 2026 (USD Billion)
  17. North America Cow Heart Tissue Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2021 to 2026 (USD Billion)
  18. North America Other Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2021 to 2026 (USD Billion)
  19. North America Transcatheter Aortic Valve Replacement Market, By End Users, From 2021 to 2026 (USD Billion)
  20. North America Hospitals Transcatheter Aortic Valve Replacement Market, By Region, From 2021 to 2026 (USD Billion)
  21. North America Ambulatory Surgical Centres Transcatheter Aortic Valve Replacement Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Cardiac Catheterization Laboratories Transcatheter Aortic Valve Replacement Market, By Region, From 2021 to 2026 (USD Billion)
  23. United States Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2021 to 2026 (USD Billion)
  24. United States Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2021 to 2026 (USD Billion)
  25. United States Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2021 to 2026 (USD Billion)
  26. United States Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2021 to 2026 (USD Billion)
  27. United States Transcatheter Aortic Valve Replacement Market, By End Users, From 2021 to 2026 (USD Billion)
  28. Canada Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2021 to 2026 (USD Billion)
  29. Canada Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2021 to 2026 (USD Billion)
  30. Canada Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2021 to 2026 (USD Billion)
  31. Canada Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2021 to 2026 (USD Billion)
  32. Canada Transcatheter Aortic Valve Replacement Market, By End Users, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample